(CIEN) Ciena - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1717793095
Stock: Networking Hardware, Software, Network Services, Automation
Total Rating 65
Risk 59
Buy Signal -0.23
| Risk 5d forecast | |
|---|---|
| Volatility | 89.2% |
| Relative Tail Risk | -20.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.62 |
| Alpha | 260.54 |
| Character TTM | |
|---|---|
| Beta | 2.090 |
| Beta Downside | 1.852 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.51% |
| CAGR/Max DD | 1.80 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 399.4767
Description: CIEN Ciena February 24, 2026
Ciena Corp (CIEN) is a global network-technology provider that sells hardware, software and services to telecom operators across the Americas, EMEA, APAC and Japan. Its business is organized into four segments: Networking Platforms (optical, routing and switching gear such as the 6500 Packet-Optical Platform and 8100 Coherent Routing); Platform Software and Services (Navigator control suite and related subscriptions); Blue Planet Automation Software and Services (orchestration, analytics and assurance tools); and Global Services (advisory, implementation and support).
In its latest quarter (Q4 2023), Ciena reported revenue of $1.12 billion, up 10% year-over-year, driven by strong demand for 5G-ready optical solutions and a record $8.3 billion order backlog. Operating margin expanded to 15.2%, reflecting higher software-subscription mix. The broader communications-equipment sector is benefitting from a 5% annual rise in global telecom capex, with carriers accelerating 5G rollouts and edge-computing investments-key tailwinds for Ciena’s product portfolio.
For a deeper dive into Ciena’s valuation and risk profile, you might explore the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 123.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 4.69 > 1.0 |
| NWC/Revenue: 47.32% < 20% (prev 62.86%; Δ -15.53% < -1%) |
| CFO/TA 0.14 > 3% & CFO 806.1m > Net Income 123.3m |
| Net Debt (490.3m) to EBITDA (386.0m): 1.27 < 3 |
| Current Ratio: 2.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (145.5m) vs 12m ago -0.34% < -2% |
| Gross Margin: 39.89% > 18% (prev 0.40%; Δ 3949 % > 0.5%) |
| Asset Turnover: 82.90% > 50% (prev 71.17%; Δ 11.73% > 0%) |
| Interest Coverage Ratio: 2.75 > 6 (EBITDA TTM 386.0m / Interest Expense TTM 89.4m) |
Altman Z'' -0.03
| A: 0.38 (Total Current Assets 3.57b - Total Current Liabilities 1.31b) / Total Assets 5.86b |
| B: -0.54 (Retained Earnings -3.17b / Total Assets 5.86b) |
| C: 0.04 (EBIT TTM 245.7m / Avg Total Assets 5.75b) |
| D: -1.03 (Book Value of Equity -3.22b / Total Liabilities 3.14b) |
| Altman-Z'' Score: -0.03 = B |
Beneish M -3.15
| DSRI: 0.66 (Receivables 975.9m/1.25b, Revenue 4.77b/4.01b) |
| GMI: 1.00 (GM 39.89% / 39.78%) |
| AQI: 1.24 (AQ_t 0.39 / AQ_t-1 0.31) |
| SGI: 1.19 (Revenue 4.77b / 4.01b) |
| TATA: -0.12 (NI 123.3m - CFO 806.1m) / TA 5.86b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of CIEN shares?
As of March 07, 2026, the stock is trading at USD 294.17 with a total of 3,922,792 shares traded.
Over the past week, the price has changed by -15.64%, over one month by +8.42%, over three months by +38.15% and over the past year by +329.88%.
Over the past week, the price has changed by -15.64%, over one month by +8.42%, over three months by +38.15% and over the past year by +329.88%.
Is CIEN a buy, sell or hold?
Ciena has received a consensus analysts rating of 4.13.
Therefore, it is recommended to buy CIEN.
- StrongBuy: 7
- Buy: 4
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CIEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 255.1 | -13.3% |
| Analysts Target Price | 255.1 | -13.3% |
CIEN Fundamental Data Overview March 06, 2026
P/E Trailing = 399.4767
P/E Forward = 76.9231
P/S = 10.1897
P/B = 17.2633
P/EG = 1.5694
Revenue TTM = 4.77b USD
EBIT TTM = 245.7m USD
EBITDA TTM = 386.0m USD
Long Term Debt = 1.52b USD (from longTermDebt, last quarter)
Short Term Debt = 30.3m USD (from shortTermDebt, last quarter)
Debt = 1.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 490.3m USD (from netDebt column, last quarter)
Enterprise Value = 48.87b USD (48.60b + Debt 1.58b - CCE 1.31b)
Interest Coverage Ratio = 2.75 (Ebit TTM 245.7m / Interest Expense TTM 89.4m)
EV/FCF = 73.46x (Enterprise Value 48.87b / FCF TTM 665.3m)
FCF Yield = 1.36% (FCF TTM 665.3m / Enterprise Value 48.87b)
FCF Margin = 13.95% (FCF TTM 665.3m / Revenue TTM 4.77b)
Net Margin = 2.59% (Net Income TTM 123.3m / Revenue TTM 4.77b)
Gross Margin = 39.89% ((Revenue TTM 4.77b - Cost of Revenue TTM 2.87b) / Revenue TTM)
Gross Margin QoQ = 42.24% (prev 38.52%)
Tobins Q-Ratio = 8.33 (Enterprise Value 48.87b / Total Assets 5.86b)
Interest Expense / Debt = 1.39% (Interest Expense 22.0m / Debt 1.58b)
Taxrate = 21.08% (32.9m / 156.3m)
NOPAT = 193.9m (EBIT 245.7m * (1 - 21.08%))
Current Ratio = 2.73 (Total Current Assets 3.57b / Total Current Liabilities 1.31b)
Debt / Equity = 0.58 (Debt 1.58b / totalStockholderEquity, last quarter 2.73b)
Debt / EBITDA = 1.27 (Net Debt 490.3m / EBITDA 386.0m)
Debt / FCF = 0.74 (Net Debt 490.3m / FCF TTM 665.3m)
Total Stockholder Equity = 2.77b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.14% (Net Income 123.3m / Total Assets 5.86b)
RoE = 4.45% (Net Income TTM 123.3m / Total Stockholder Equity 2.77b)
RoCE = 5.72% (EBIT 245.7m / Capital Employed (Equity 2.77b + L.T.Debt 1.52b))
RoIC = 4.50% (NOPAT 193.9m / Invested Capital 4.31b)
WACC = 13.23% (E(48.60b)/V(50.18b) * Re(13.62%) + D(1.58b)/V(50.18b) * Rd(1.39%) * (1-Tc(0.21)))
Discount Rate = 13.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.82%
[DCF] Terminal Value 50.74% ; FCFF base≈549.3m ; Y1≈360.6m ; Y5≈164.5m
[DCF] Fair Price = 8.81 (EV 1.74b - Net Debt 490.3m = Equity 1.25b / Shares 141.5m; r=13.23% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -15.68 | EPS CAGR: -45.39% | SUE: -4.0 | # QB: 0
Revenue Correlation: 72.20 | Revenue CAGR: 13.37% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-04-30): EPS=1.21 | Chg7d=+0.006 | Chg30d=+0.006 | Revisions Net=+12 | Analysts=14
EPS current Year (2026-10-31): EPS=5.37 | Chg7d=+0.025 | Chg30d=+0.025 | Revisions Net=+13 | Growth EPS=+103.2% | Growth Revenue=+24.9%
EPS next Year (2027-10-31): EPS=7.05 | Chg7d=+0.164 | Chg30d=+0.164 | Revisions Net=+1 | Growth EPS=+31.4% | Growth Revenue=+17.3%
[Analyst] Revisions Ratio: +1.00 (12 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 13.4% (Discount Rate 13.6% - Earnings Yield 0.3%)
[Growth] Growth Spread = +14.5% (Analyst 27.9% - Implied 13.4%)
P/E Forward = 76.9231
P/S = 10.1897
P/B = 17.2633
P/EG = 1.5694
Revenue TTM = 4.77b USD
EBIT TTM = 245.7m USD
EBITDA TTM = 386.0m USD
Long Term Debt = 1.52b USD (from longTermDebt, last quarter)
Short Term Debt = 30.3m USD (from shortTermDebt, last quarter)
Debt = 1.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 490.3m USD (from netDebt column, last quarter)
Enterprise Value = 48.87b USD (48.60b + Debt 1.58b - CCE 1.31b)
Interest Coverage Ratio = 2.75 (Ebit TTM 245.7m / Interest Expense TTM 89.4m)
EV/FCF = 73.46x (Enterprise Value 48.87b / FCF TTM 665.3m)
FCF Yield = 1.36% (FCF TTM 665.3m / Enterprise Value 48.87b)
FCF Margin = 13.95% (FCF TTM 665.3m / Revenue TTM 4.77b)
Net Margin = 2.59% (Net Income TTM 123.3m / Revenue TTM 4.77b)
Gross Margin = 39.89% ((Revenue TTM 4.77b - Cost of Revenue TTM 2.87b) / Revenue TTM)
Gross Margin QoQ = 42.24% (prev 38.52%)
Tobins Q-Ratio = 8.33 (Enterprise Value 48.87b / Total Assets 5.86b)
Interest Expense / Debt = 1.39% (Interest Expense 22.0m / Debt 1.58b)
Taxrate = 21.08% (32.9m / 156.3m)
NOPAT = 193.9m (EBIT 245.7m * (1 - 21.08%))
Current Ratio = 2.73 (Total Current Assets 3.57b / Total Current Liabilities 1.31b)
Debt / Equity = 0.58 (Debt 1.58b / totalStockholderEquity, last quarter 2.73b)
Debt / EBITDA = 1.27 (Net Debt 490.3m / EBITDA 386.0m)
Debt / FCF = 0.74 (Net Debt 490.3m / FCF TTM 665.3m)
Total Stockholder Equity = 2.77b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.14% (Net Income 123.3m / Total Assets 5.86b)
RoE = 4.45% (Net Income TTM 123.3m / Total Stockholder Equity 2.77b)
RoCE = 5.72% (EBIT 245.7m / Capital Employed (Equity 2.77b + L.T.Debt 1.52b))
RoIC = 4.50% (NOPAT 193.9m / Invested Capital 4.31b)
WACC = 13.23% (E(48.60b)/V(50.18b) * Re(13.62%) + D(1.58b)/V(50.18b) * Rd(1.39%) * (1-Tc(0.21)))
Discount Rate = 13.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.82%
[DCF] Terminal Value 50.74% ; FCFF base≈549.3m ; Y1≈360.6m ; Y5≈164.5m
[DCF] Fair Price = 8.81 (EV 1.74b - Net Debt 490.3m = Equity 1.25b / Shares 141.5m; r=13.23% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -15.68 | EPS CAGR: -45.39% | SUE: -4.0 | # QB: 0
Revenue Correlation: 72.20 | Revenue CAGR: 13.37% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-04-30): EPS=1.21 | Chg7d=+0.006 | Chg30d=+0.006 | Revisions Net=+12 | Analysts=14
EPS current Year (2026-10-31): EPS=5.37 | Chg7d=+0.025 | Chg30d=+0.025 | Revisions Net=+13 | Growth EPS=+103.2% | Growth Revenue=+24.9%
EPS next Year (2027-10-31): EPS=7.05 | Chg7d=+0.164 | Chg30d=+0.164 | Revisions Net=+1 | Growth EPS=+31.4% | Growth Revenue=+17.3%
[Analyst] Revisions Ratio: +1.00 (12 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 13.4% (Discount Rate 13.6% - Earnings Yield 0.3%)
[Growth] Growth Spread = +14.5% (Analyst 27.9% - Implied 13.4%)